Agenus Inc.
- AGEN
- NASDAQ
- Biotechnology
- Immuno-Oncology Biotech
- Antibody Discovery (Retrocyte Display)
$6.04
Today −9.58%Quote Oct 16, 2026, 08:00 PM UTC
−16.34%over the last month
Max drawdown −39.2%From 1-month high −39.2%3 months +21.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$272.8M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$25.00
+313.9% from here
Floor
$5.50
8.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AGENPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
81